Skip to main content
Caplight Logo









Nuream

Nuream

Private
Wilmington, North CarolinaEnterprise Softwarehttps://nuream.ai/

Last Round

Grant

May 21, 2026

Total Funding Raised

$1.84M

Company Overview

Nuream is a neurodata science company that develops fabric-as-a-sensor technology to monitor brain activity and sleep patterns for health insights and disease detection.

Sector

Enterprise Software

Verticals

Document Management, Workflow Automation, NLP & Conversational AI

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Data as a Service

AI Layer

Infrastructure

Keywords

document processingautomated data extractionintelligent document processingIDPworkflow automationcomputer visionunstructured datadata entry automationOCRoptical character recognitionenterprise SaaSERP integrationdocument managementback-office automationAI-powered extraction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuream Comparables

Compare Nuream with similar companies based on industry and business-model similarity.

No public comparables are available for Nuream. Request access to learn about comparables coverage.

Request access

Nuream Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 21, 2026
GrantMay 21, 2026
GrantApr 8, 2025
Pre SeedJan 22, 2025

Nuream Investors

Notable investors and investment history

Nuream investors
InvestorRounds
NC IDEAGrant
NCInnovationGrant

Nuream Filings

Explore SEC and related filing metadata, where available.

Nuream filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuream's valuation, stock price, and market status.

Is Nuream a public or private company?

Nuream is a private company.

What is the current stock price of Nuream?

Nuream is a private company with no public stock price. No recent secondary market data is available.

How much is Nuream worth (valuation)?

Valuation information for Nuream is not publicly available.

Can I buy Nuream stock?

Nuream shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuream's last funding round?

Nuream's most recent funding round was Grant on May 21, 2026.

Who are the main investors in Nuream?

Key investors in Nuream include NC IDEA, NCInnovation.

Will Nuream IPO soon?

No public IPO plans have been announced for Nuream.

How can I track Nuream secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuream's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, North Carolina
Year Founded2023
Last FundingMay 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?